| Literature DB >> 21067593 |
J P Souza1, Am Gülmezoglu, P Lumbiganon, M Laopaiboon, G Carroli, B Fawole, P Ruyan.
Abstract
BACKGROUND: There is worldwide debate about the appropriateness of caesarean sections performed without medical indications. In this analysis, we aim to further investigate the relationship between caesarean section without medical indication and severe maternal outcomes.Entities:
Mesh:
Year: 2010 PMID: 21067593 PMCID: PMC2993644 DOI: 10.1186/1741-7015-8-71
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Figure 1Study profile. *Includes laparotomy for ruptured uterus.
Total number of deliveries and facilities by country, and the percentages of deliveries by mode and country
| Vaginal Delivery | Caesarean section without indications | Caesarean section with indications | Total deliveries | Total facilities | ||||
|---|---|---|---|---|---|---|---|---|
| Spontaneous | Operative | Antepartum | Intrapartum | Antepartum | Intrapartum | |||
| % | % | % | % | % | % | n | n | |
| 80.5 | 5.9 | 0.04 | 0.1 | 5.9 | 7.5 | 15,578 | 18 | |
| 97.7 | 0.8 | 0.1 | 0.02 | 1.0 | 0.5 | 6,322 | 20 | |
| 84.8 | 2.3 | 0.1 | 0.1 | 1.4 | 11.4 | 8,804 | 21 | |
| 82.9 | 1.5 | 0.1 | 0.5 | 3.2 | 11.8 | 19,968 | 20 | |
| 91.5 | 3.2 | 0.02 | 0.2 | 0.4 | 4.8 | 8,275 | 11 | |
| 81.1 | 4.4 | 0.1 | 0.3 | 3.6 | 10.5 | 8,939 | 21 | |
| 85.4 | 1.2 | 0.1 | 0.3 | 2.1 | 10.9 | 13,836 | 20 | |
| 62.1 | 2.8 | 0.2 | 0.1 | 17.8 | 17.0 | 10,689 | 14 | |
| 68.5 | 2.0 | 0.3 | 0.2 | 15.4 | 13.6 | 15,129 | 19 | |
| 61.7 | 2.7 | 0.02 | 0.1 | 16.6 | 18.8 | 12,642 | 17 | |
| 59.2 | 0.5 | 0.1 | 0.6 | 7.8 | 31.8 | 12,414 | 18 | |
| 60.4 | 1.9 | 0.1 | 0.1 | 15.8 | 21.8 | 20,883 | 21 | |
| 69.1 | 0.1 | 0.1 | 0.2 | 7.7 | 22.8 | 5,636 | 8 | |
| 57.3 | 0.8 | 1.2 | 0.9 | 18.1 | 21.7 | 3,460 | 17 | |
| 65.4 | 0.6 | 0.01 | 0.0 | 13.2 | 20.8 | 16,040 | 17 | |
| 77.6 | 7.7 | 0.04 | 0.2 | 2.6 | 11.8 | 5,565 | 5 | |
| 52.6 | 1.2 | 9.3 | 2.3 | 19.7 | 14.9 | 14,541 | 21 | |
| 79.4 | 2.9 | 0.1 | 0.2 | 3.6 | 13.8 | 24,682 | 20 | |
| 74.1 | 6.1 | 0.1 | 0.0 | 13.9 | 5.9 | 3,300 | 10 | |
| 76.0 | 3.8 | 0.04 | 0.1 | 6.2 | 14.0 | 8,489 | 8 | |
| 78.4 | 2.8 | 0.04 | 0.1 | 8.0 | 10.3 | 13,295 | 6 | |
| 65.9 | 3.5 | 0.5 | 0.2 | 20.2 | 9.8 | 15,024 | 14 | |
| 61.6 | 4.3 | 0.3 | 0.1 | 13.4 | 20.2 | 9,745 | 12 | |
| 62.2 | 2.2 | 0.2 | 0.8 | 4.3 | 30.2 | 13,309 | 15 | |
| 71.7 | 2.6 | 0.6 | 0.3 | 9.4 | 15.4 | 286,565 | 373 | |
Selected maternal characteristics and mode of delivery (%)
| Vaginal delivery | Caesarean section without indications | Caesarean section with indications | Total | ||||
|---|---|---|---|---|---|---|---|
| Spontaneous | Operative | Antepartum | Intrapartum | Antepartum | Intrapartum | ||
| N = 205,551 | N = 7,296 | N = 1,735 | N = 950 | N = 27,011 | N = 44,022 | N = 286,565 | |
| Marital status (single) | 13.5 | 9.3 | 2.7 | 6.0 | 11.8 | 10.7 | 12.7 |
| Maternal age | |||||||
| ≤16 years | 2.5 | 2 | 0.1 | 1.9 | 1.4 | 2.4 | 2.3 |
| 16 to 35 | 87.8 | 85.7 | 89.4 | 85.9 | 80.1 | 86 | 86.8 |
| ≥35 | 9.7 | 12.3 | 10.6 | 12.3 | 18.5 | 11.6 | 10.9 |
| Years of education | |||||||
| <7 | 30.9 | 28.4 | 11.4 | 20.5 | 18.4 | 24.7 | 28.6 |
| 7 to 12 | 57.1 | 54.9 | 59.0 | 56.1 | 59.4 | 57.6 | 57.4 |
| >12 | 12 | 16.7 | 29.7 | 23.4 | 22.2 | 17.7 | 14.1 |
| Primiparous | 41.2 | 57.3 | 73.3 | 58.8 | 37.6 | 49.7 | 42.8 |
| Low birth weight | 10.0 | 14.1 | 3.1 | 5.4 | 14.9 | 10.1 | 10.5 |
| Fetal or neonatal death | 2.0 | 2.4 | 1.6 | 3.6 | 2.6 | 2.6 | 2.1 |
| Caesarean delivery in the last pregnancy | 2 | 5.9 | 6.7 | 11.9 | 39.3 | 23.5 | 9 |
| Induced labour | 9.9 | 15.4 | 0.0 | 13.9 | 0.0 | 13.9 | 9.7 |
| Prelabour rupture of membranes | 9.4 | 13.2 | 8.4 | 16.0 | 8.7 | 15.3 | 10.3 |
| Pregnancy induced hypertension | 2.8 | 5.3 | 2.9 | 3.2 | 8.5 | 5.5 | 3.8 |
| Pre-eclampsia | 1.6 | 3.2 | 1.3 | 1.3 | 8.9 | 4.8 | 2.8 |
| Eclampsia | 0.2 | 0.8 | 0.1 | 0.3 | 1 | 0.6 | 0.4 |
| Chronic hypertension | 0.6 | 1 | 0.2 | 0.2 | 2.4 | 1.2 | 0.8 |
| Vaginal bleeding in second half of pregnancy | 0.9 | 1.2 | 0.6 | 0.9 | 3.6 | 2 | 1.3 |
| Suspected fetal growth impairment | 0.8 | 1 | 0.3 | 0.7 | 2.5 | 1 | 1 |
| Breech or other non-cephalic presentation | 1 | 25.1 | 0 | 0 | 14.7 | 12.6 | 4.7 |
| Referred for complication related to pregnancy | 18.8 | 23.9 | 9.1 | 14.2 | 34 | 28.8 | 21.8 |
| HIV | 0.8 | 0.5 | 0.5 | 1.4 | 1 | 0.9 | 0.8 |
| Cardiac/Renal diseases | 0.3 | 1 | 0.5 | 0.5 | 1.1 | 0.5 | 0.5 |
| Chronic respiratory conditions | 0.5 | 0.7 | 0.3 | 0.2 | 1 | 0.6 | 0.6 |
| Diabetes mellitus | 0.4 | 0.7 | 1.5 | 0.3 | 2.6 | 1 | 0.7 |
| Malaria | 3.3 | 2.7 | 0.2 | 1.3 | 0.4 | 1.1 | 2.6 |
| Sickle cell anaemia | 0.3 | 0.1 | 0.0 | 0.3 | 0.5 | 0.4 | 0.3 |
| Severe anaemia | 0.5 | 0.8 | 0.1 | 0.5 | 0.8 | 0.5 | 0.6 |
| Pyelonephritis or urinary infection | 5.9 | 4.4 | 0.6 | 5.4 | 8.4 | 8.6 | 6.5 |
| Other medical conditions | 5.3 | 5.3 | 10.2 | 5.7 | 12.6 | 8.2 | 6.5 |
The relationship between mode of delivery and severe maternal outcomes (that is, death, admission to ICU, blood transfusion, hysterectomy)
| Maternal outcomes | n/N (%) | Adjusted OR [95%CI] |
|---|---|---|
| Spontaneous (reference) | 196/205,551 (0.10) | 1 |
| Operative | 34/7,296 (0.47) | 2.9 (1.84 to 4.56) |
| Antepartum without indications | Not estimated | |
| Intrapartum without indications | 3.21 (0.78 to 13.2) | |
| Antepartum with indications | 1.51 (0.97 to 2.33) | |
| Intrapartum with indications | 1.7 (1.24 to 2.33) | |
| Spontaneous (reference) | 1,189/205,551 (0.58) | 1 |
| Operative | 172/7,296 (2.36) | 2.27 (1.89 to 2.73) |
| Antepartum without indications | 30.75 (18.12 to 52.17) | |
| Intrapartum without indications | 58.85 (41.46 to 83.52) | |
| Antepartum with indications | 63.4 (56.32 to 71.36) | |
| Intrapartum with indications | 51.3 (46.56 to 56.59) | |
| Spontaneous (reference) | 1,940/205,303 (0.94) | 1 |
| Operative | 198/7,287 (2.72) | 2.11 (1.79 to 2.48) |
| Antepartum without indications | 1.79 (0.91 to 3.52) | |
| Intrapartum without indications | 3.7 (2.24 to 6.1) | |
| Antepartum with indications | 3.75 (3.39 to 4.14) | |
| Intrapartum with indications | 3.85 (3.55 to 4.16) | |
| Spontaneous (reference) | 82/205,299 (0.04) | 1 |
| Operative | 11/7,278 (0.15) | 3.38 (1.73 to 6.59) |
| Antepartum without indications | Not estimated | |
| Intrapartum without indications | 13.53 (4.79 to 38.2) | |
| Antepartum with indications | 6.11 (4.38 to 8.52) | |
| Intrapartum with indications | 6.68 (4.91 to -9.09) | |
| Spontaneous (reference) | 3,147/205,551 (1.53) | 1 |
| Operative | 346/7,296 (4.74) | 1.84 (1.62 to 2.1) |
| Antepartum without indications | 5.93 (3.88 to 9.05) | |
| Intrapartum without indications | 14.29 (10.91 to 18.72) | |
| Antepartum with indications | 13.28 (12.3 to 14.34) | |
| Intrapartum with indications | 12.05 (11.33 to 12.82) |
*Total number of years attended school, birth weight, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, suspected fetal growth impairment, vaginal bleeding in second half of pregnancy, Breech or other non-cephalic presentation, referred for complication related to pregnancy or delivery, induced labour, HIV positive, Any other medical complication during pregnancy (excluding chronic hypertension) and incentive for caesarean section (no missing data for this outcome)
**Maternal age, total number of years attended school, birth weight, prelabour rupture of membranes, pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, vaginal bleeding in second half of pregnancy, Referred for complication related to pregnancy or delivery, induced labour, HIV positive, any other medical complication during pregnancy (excluding chronic hypertension), incentive for caesarean section and country (no missing data for this outcome)
†Maternal age, total number of years attended school, primiparaous, birth weight, neonatal death or stillbirth, pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, vaginal bleeding in second half of pregnancy, any antenatal antibiotic treatment, referred for complication related to pregnancy or delivery, induced labour, hiv positive, any other medical complication during pregnancy (excluding chronic hypertension), incentive for caesarean section and country (395 participants with missing data for this outcome)
†† Maternal age, Primiparaous, birth weight, vaginal bleeding in second half of pregnancy, referred for complication related to pregnancy or delivery, any other medical complication during pregnancy (excluding chronic hypertension), country and incentive for caesarean section (501 participants with missing data for this outcome)
Maternal age, total number of years attended school, birth weight, neonatal death or stillbirth, prelabour rupture of membranes, pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, vaginal bleeding in the second half of pregnancy, any antenatal antibiotic treatment, breech or other non-cephalic presentation, referred for complication related to pregnancy or delivery, induced labour, hiv positive, any other medical complication during pregnancy (excluding chronic hypertension), country and incentive for caesarean section (data available for at least one of the included outcomes for all participants)
Relationship between mode of delivery and severe maternal outcomes by continent
| Severe Maternal Outcomes | No (%) | Adjusted OR [95%CI] |
|---|---|---|
| Spontaneous (reference) | 1011/69,364 (1.46) | 1 to |
| Operative | 151/2,298 (6.57) | 2.58 (2.12-3.15) |
| Antepartum without indications | 71.29 (32.06 to 158.55) | |
| Intrapartum without indications | 40.67 (24.56-67.33) | |
| Antepartum with indications | 88.61 (74.88 to 104.86) | |
| Intrapartum with indications | 54.26 (47.81 to 61.59) | |
| Spontaneous (reference) | 946/61130 (1.55) | 1 |
| Operative | 50/1533 (3.26) | 2.2 (1.62 to 2.99) |
| Antepartum without indications | 1.94 (0.77 to 4.9) | |
| Intrapartum without indications | 4 (2.05 to 7.82) | |
| Antepartum with indications | 3.04 (2.71 to 3.41) | |
| Intrapartum with indications | 1.91 (1.71 to 2.13) | |
| Spontaneous (reference) | 1190/75057 (1.59) | 1 |
| Operative | 145/3465 (4.18) | 1.91 (1.56 to 2.35) |
| Antepartum without indications | 2.14 (1.04 to 4.43) | |
| Intrapartum without indications | 12.86 (8.83 to 18.73) | |
| Antepartum with indications | 8.09 (7.12 to 9.18) | |
| Intrapartum with indications | 11.61 (10.56 to 12.76) |
†Maternal age, Total number of years attended school, Primiparaous, Birth weight, Neonatal death or stillbirth, Caesarean section at last pregnancy, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Suspected fetal growth impairment, Vaginal bleeding in 2nd half of pregnancy, Referred for complication related to pregnancy or delivery, Any other medical complication during pregnancy (excluding chronic hypertension), Country, Incentive for caesarean section
††Birth weight, Prelabour rupture of membranes, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Vaginal bleeding in 2nd half of pregnancy, Any antenatal antibiotic treatment, Referred for complication related to pregnancy or delivery, Induced labour, HIVPOS, Any other medical complication during pregnancy (excluding chronic hypertension) and Incentive for caesarean section
††† Maternal age, Total number of years attended school, Primiparous, Birth weight, Neonatal death or stillbirth, Prelabour rupture of membranes, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Vaginal bleeding in 2nd half of pregnancy, Breech or other non-cephalic precentation, Referred for complication related to pregnancy or delivery, HIVPOS, Any other medical complication during pregnancy (excluding chronic hypertension), Country and Complexity of index
(Differently from the previous Asian specific analysis [7], the severe maternal outcomes included in this analysis are: death, admission to ICU, blood transfusion and hysterectomy)
Perinatal outcomes among singleton and first child of multiple births by mode of delivery
| Perinatal outcomes | n/N (%) | Adjusted OR [95%CI] |
|---|---|---|
| Spontaneous (reference) | ||
| Operative | ||
| Antepartum without indications | ||
| Intrapartum without indications | ||
| Antepartum with indications | ||
| Intrapartum with indications | ||
| Spontaneous (reference) | ||
| Operative | ||
| Antepartum without indications | ||
| Intrapartum without indications | ||
| Antepartum with indications | ||
| Intrapartum with indications | ||
| Spontaneous (reference) | ||
| Operative | ||
| Antepartum without indications | ||
| Intrapartum without indications | ||
| Antepartum with indications | ||
| Intrapartum with indications | ||
| Spontaneous (reference) | ||
| Operative | ||
| Antepartum without indications | ||
| Intrapartum without indications | ||
| Antepartum with indications | ||
| Intrapartum with indications | ||
| Spontaneous (reference) | ||
| Operative | ||
| Antepartum without indications | ||
| Intrapartum without indications | ||
| Antepartum with indications | ||
| Intrapartum with indications |
† Maternal age, Total number of years attended school, birth weight, Neonatal death or stillbirth, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Vaginal bleeding in 2nd half of pregnancy, Any antenatal antibiotic treatment, Referred for complication related to pregnancy or delivery, Induced labour, Any other medical complication during pregnancy (excluding chronic hypertension), country and gestational age
†† Maternal age, Total number of years attended school, birth weight, Neonatal death or stillbirth, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Vaginal bleeding in 2nd half of pregnancy, Referred for complication related to pregnancy or delivery, Any other medical complication during pregnancy (excluding chronic hypertension) and gestational age
‡ Total number of years attended school, birth weight, Neonatal death or stillbirth, Vaginal bleeding in 2nd half of pregnancy, Referred for complication related to pregnancy or delivery, Induced labour, country and gestational age
‡‡ Maternal age, Total number of years attended school, Primigravida, birth weight, Neonatal death or stillbirth, Caesarean section at last pregnancy, Prelabour rupture of membranes, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Suspected fetal growth impairment, Any antenatal antibiotic treatment, Breech or other non-cephalic presentation, Referred for complication related to pregnancy or delivery, Induced labour, Any other medical complication during pregnancy (excluding chronic hypertension), country, complexity of index and gestational age
‡‡‡ Maternal age, Total number of years attended school, birth weight, Neonatal death or stillbirth, Caesarean section at last pregnancy, Prelabour rupture of membranes, Pregnancy induced hypertension or preeclampsia or eclampsia or chronic hypertension, Suspected fetal growth impairment, Vaginal bleeding in 2nd half of pregnancy, Breech or other non-cephalic presentation, Referred for complication related to pregnancy or delivery, Induced labour, Any other medical complication during pregnancy (excluding chronic hypertension), country, complexity of index and gestational age